Skip to main content
Premium Trial:

Request an Annual Quote

Clinical Data Defines Distinct PGx, Cogenic and Diagnostic Units: Mar 1, 2006 (rev. 2)

NEW YORK, March 1, (GenomeWeb News) - Clinical Data announced today the division of its business into three units.

 

They are PGxHealth, Cogenics, and Vital Diagnostics.

 

The PGX Health division includes assets from newly acquired Genaissance to develop therapeutic diagnostics. The unit is developing CNS, cardiovascular, and oncology tests, the company said in a statement.

 

The Cogenics unit, which represents the combined operations and marketing infrastructure of Genaissance, Lark and Icoria to provide comprehensive pharmacogenomics and molecular services, is developing GLP-validated and research assays.

 

Vital Diagnostics, derived from the operations of Clinical Data, Vital, and Electa Labs, is geared toward IVD services for customers in 100 countries.

The Scan

Tens of Millions Saved

The Associated Press writes that vaccines against COVID-19 saved an estimated 20 million lives in their first year.

Supersized Bacterium

NPR reports that researchers have found and characterized a bacterium that is visible to the naked eye.

Also Subvariants

Moderna says its bivalent SARS-CoV-2 vaccine leads to a strong immune response against Omicron subvariants, the Wall Street Journal reports.

Science Papers Present Gene-Edited Mouse Models of Liver Cancer, Hürthle Cell Carcinoma Analysis

In Science this week: a collection of mouse models of primary liver cancer, and more.